Gene expression of FZD5, DVL3, RELA, MAPK9, CTNNB1, and SNAI1 is higher in metastatic prostate tumors as compared to primary prostate tumors (Figure 6). This evidence concerns the gene CTNNB1 and prostate neoplasm.